AlphaYou
Overview
Smart money at a glance
Filings to Oct 7, 2026Net buying: insiders sold $0 and bought $93K on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- +$93K netNet buying
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, latest quarter
- NoneNo large changes
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Market overview
Fundamentals Oct 6- Open
- $1.13
- 52-wk high
- $27.36
- High
- $1.16
- 52-wk low
- $1.11
- Low
- $1.12
- Prev close
- $1.13
- Mkt cap
- $159.8M
- Volume
- 154.1K
- Beta
- 0.19
- P/S
- 6821.1x
- P/B
- 89.3x
- Profit margin
- +0.0%
- Op margin
- -282663.0%
- ROE
- -871.0%
What do analysts expect?
No analyst estimates.
Questions about VRXA filings
Are insiders buying or selling Veraxa Biotech AG Ordinary Shares (VRXA) stock?
Net buying: insiders sold $0 and bought $93K of VRXA stock on the open market in the 90 days to Oct 7, 2026, according to SEC Form 4 filings. The largest was Baumann, Oliver Rolf (Director), who bought $75K. The latest filing was on Sep 29, 2026.
Which members of Congress have traded VRXA recently?
None. No member of Congress disclosed a VRXA trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this VRXA smart-money data?
This summary uses filings available on Oct 7, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
2 funds hold a position and insiders have been net buying.
What insiders are doing
Buys (3)
- HW
Hosseinion Warren
$10K
bought
- BO
Baumann Oliver Rolf
$75K
bought
- AC
Antz Christoph Rudiger
$8K
bought
How top traders are positioned
No tracked top-trader positions in VRXA right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Results versus expectations
No earnings history.
What the street expects next
Financials
Is the business strong?
This company is running thin margins.
- Net margin
- 0.0%
- Market cap
- $160M
Valuation
- P/S6821.09
- P/B89.31
Quality
- Operating margin-282663.0%
- ROE-871.0%
- ROA-50.0%
Growth
- Beta0.19
Technicals
Price structure
This stock is under pressure, and looks oversold after a sharp drop.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace